These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [Fluoroquinolones]. Baykal M; Akalin E Mikrobiyol Bul; 1987 Apr; 21(2):151-7. PubMed ID: 3482120 [TBL] [Abstract][Full Text] [Related]
11. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans]. Renaudin H; Quentin C; de Barbeyrac B; Bebear C Pathol Biol (Paris); 1988 May; 36(5):496-9. PubMed ID: 3136430 [TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility of aerobic gram-negative blood culture isolates to oxolinic acid, norfloxacin, ciprofloxacin, enoxacin, pefloxacin, ofloxacin and oxo-enoxacin. Van der Auwera P Infection; 1986; 14(3):142-4. PubMed ID: 2942489 [TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro activities of ciprofloxacin, enoxacin, norfloxacin, ofloxacin and pefloxacin against Bacteroides fragilis and Clostridium difficile. Edlund C; Nord CE Scand J Infect Dis; 1986; 18(2):149-51. PubMed ID: 2939556 [TBL] [Abstract][Full Text] [Related]
14. [Therapeutic drug monitoring of fluoroquinolone]. Matsumoto F; Takahashi T; Morita M Nihon Rinsho; 1990 Feb; 48 Suppl():1217-22. PubMed ID: 2355524 [No Abstract] [Full Text] [Related]
15. The pharmacokinetics and tissue penetration of the fluoroquinolones. Bergeron MG Clin Invest Med; 1989 Feb; 12(1):20-7. PubMed ID: 2920479 [TBL] [Abstract][Full Text] [Related]
16. Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin; a common secretory pathway? Griffiths NM; Hirst BH; Simmons NL J Pharmacol Exp Ther; 1994 May; 269(2):496-502. PubMed ID: 8182517 [TBL] [Abstract][Full Text] [Related]
17. The role of quinolones in staphylococcal infection. Shah PM J Chemother; 1989 Aug; 1(4):253-6. PubMed ID: 2809692 [TBL] [Abstract][Full Text] [Related]
18. Quantitative determination of ofloxacin, ciprofloxacin, norfloxacin and pefloxacin in serum by high pressure liquid chromatography. Groeneveld AJ; Brouwers JR Pharm Weekbl Sci; 1986 Feb; 8(1):79-84. PubMed ID: 2938073 [TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacokinetics of the newer antibacterial 4-quinolones. Neuman M Clin Pharmacokinet; 1988 Feb; 14(2):96-121. PubMed ID: 3282749 [TBL] [Abstract][Full Text] [Related]
20. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens. Naber KG; Well M; Hollauer K; Kirchbauer D; Witte W Chemotherapy; 1998; 44(2):77-84. PubMed ID: 9551236 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]